NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,768 | +43.9% | 92 | +170.6% | 0.00% | – |
| Q1 2023 | $1,229 | – | 34 | +385.7% | 0.00% | – |
| Q3 2022 | $0 | – | 7 | +16.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 6 | -88.0% | 0.00% | – |
| Q1 2022 | $4,000 | -84.6% | 50 | -84.2% | 0.00% | -100.0% |
| Q4 2021 | $26,000 | +333.3% | 317 | +476.4% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 55 | -17.9% | 0.00% | -100.0% |
| Q2 2018 | $5,000 | -16.7% | 67 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $6,000 | +20.0% | 67 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | 0.0% | 67 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | -16.7% | 67 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $6,000 | -50.0% | 67 | -50.0% | 0.00% | 0.0% |
| Q1 2017 | $12,000 | +140.0% | 134 | +100.0% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |